Multifunctional Nanoassemblies for Ligand-directed Imaging and Therapy of Endocri
用于内分泌配体定向成像和治疗的多功能纳米组件
基本信息
- 批准号:8735865
- 负责人:
- 金额:$ 33.02万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-08-01 至 2016-07-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdenocarcinomaAdhesionsArchivesAreaBacteriophagesBlood VesselsCancer BiologyCancer CenterCollaborationsComputer SimulationDetectionDevelopmentDiseaseDrug CarriersEarly DiagnosisEndocrineEngineeringGenerationsGoldHeatingHomingHumanImageImmunohistochemistryInfrared RaysIslet Cell TumorLigandsLiposomesMalignant NeoplasmsMalignant neoplasm of ovaryMethodsModalityMolecularNanotechnologyOutputOvarianPancreasPeptide LibraryPhage DisplayPharmacologic SubstancePositron-Emission TomographyPropertyRaman Spectrum AnalysisRelative (related person)SamplingScienceServicesShapesSignal TransductionSiliconSpecificityStreptozocinSurfaceSurface PropertiesSystemTexasTherapeuticTherapeutic AgentsTherapeutic EffectThermal Ablation TherapyTissuesTracerTransgenic MiceTranslatingVascular EndotheliumX-Ray Computed Tomographyangiogenesisbasebiomathematicschemical propertychemotherapyclinical applicationcombinatorialdensitydesignhuman diseaseimaging probein vivomathematical modelmolecular imagingmouse modelnanonanoassemblynanoengineeringnanomedicinenanoparticlenoveloncologyovarian neoplasmpancreatic neoplasmparticlephysical propertyreceptorreceptor expressionresponsescaffoldscreeningselective expressionsimulationtargeted deliverytooltool developmenttumorvascular bed
项目摘要
PROJECT TITLE: Multifunctional Nanoassemblies for Ligand-Directed Imaging and Therapy of Endocrine Pancreatic Tumors
PROJECT SUMMARY: The development of tools for the targeted delivery of Imaging-probes and therapeufic agents has become the focus of intense efforts in the context of many human diseases. The in vivo screening method in which phage can be selected from engineered combinatorial peptide libraries for their ability to target specific vascular beds has uncovered a vascular address system that allows specific angiogenesis-related targeting to blood vessels in cancer. This phage display-based targeting Is expanded by the direct-assembly of gold and nanoporous silicon nanoparticles onto phage for nanomedical applications. Through exploiting the nanodimensions of the phage particle as a molecular network we generated biologically active nanoassemblies (NAs) with concomitant unique and tunable chemical and physical properties. These properties include near-infrared (NIR) radiation conversion to heat, enhancement of fluorescent signals, NIR surface enhanced Raman scattering (SERS) and the ability to conjugate and incorporate therapies or imaging-tracers. This tuning capability combined with the programmable tissue targefing affords the Integrafion of multiple funcfionalities into a single NA and serves as a complementary and non-mutually exclusive tool among different applicafions, including chemotherapy targeting and molecular imaging. Project 4 aims to develop the ligand-directed Si particles- phage- Au particles NAs as novel systems for targeted imaging and therapy in endocrine pancreatic tumors. These efforts will be translated into wide-ranging clinical applications.
项目名称:用于配体指导成像和内分泌胰腺肿瘤疗法的多功能纳米仪表
项目摘要:开发针对成像探针和治疗剂的目标交付工具的开发已成为许多人类疾病的强烈努力的重点。可以从工程组合肽库中选择噬菌体以靶向特定血管床的能力的体内筛查方法,它发现了一个血管地址系统,该系统允许特定的血管生成相关的靶向癌症中的血管。基于噬菌体显示的靶向是通过黄金和纳米多孔硅纳米颗粒的直接组装扩展到纳米医学应用的噬菌体上的。通过利用噬菌体颗粒的纳米二维为分子网络,我们生成具有独特且可调化的化学和物理特性的生物活性纳米夹(NAS)。这些特性包括近红外(NIR)辐射转换为热量,增强荧光信号,NIR表面增强的拉曼散射(SERS)以及结合并结合疗法或成像跟踪器的能力。这种调整能力与可编程组织的结合可以使多个函数的整合到单个NA中,并在不同的应用程序中充当互补和非纯粹的独占工具,包括靶向化学疗法和分子成像。项目4旨在开发配体指导的Si颗粒 - 噬菌体颗粒NAS作为内分泌胰腺肿瘤中靶向成像和治疗的新型系统。这些努力将转化为广泛的临床应用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
STEVEN K. LIBUTTI其他文献
STEVEN K. LIBUTTI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('STEVEN K. LIBUTTI', 18)}}的其他基金
Rutgers Optimizes Innovation (ROI) Program
罗格斯大学优化创新 (ROI) 计划
- 批准号:
10316635 - 财政年份:2020
- 资助金额:
$ 33.02万 - 项目类别:
Rutgers Optimizes Innovation (ROI) Program
罗格斯大学优化创新 (ROI) 计划
- 批准号:
10475236 - 财政年份:2019
- 资助金额:
$ 33.02万 - 项目类别:
Rutgers Optimizes Innovation (ROI) Program
罗格斯大学优化创新 (ROI) 计划
- 批准号:
10022340 - 财政年份:2019
- 资助金额:
$ 33.02万 - 项目类别:
Rutgers Optimizes Innovation (ROI) Program
罗格斯大学优化创新 (ROI) 计划
- 批准号:
10240645 - 财政年份:2019
- 资助金额:
$ 33.02万 - 项目类别:
Training of Surgeons for Studies of the Tumor Microenvironment
外科医生肿瘤微环境研究培训
- 批准号:
8999649 - 财政年份:2015
- 资助金额:
$ 33.02万 - 项目类别:
Development of Standardized Electronic Treatment Plan Builds for NCI-Supported Clinical Trials Applicable Across Clinical Research Sites; In conjunction with the Big Ten EHR Consortium
为 NCI 支持的临床试验开发标准化电子治疗计划,适用于各个临床研究中心;
- 批准号:
10225772 - 财政年份:1997
- 资助金额:
$ 33.02万 - 项目类别:
T-Cell Receptor Discovery for Engineered T-cell Therapy for Human Cancers
用于人类癌症工程 T 细胞疗法的 T 细胞受体发现
- 批准号:
10317346 - 财政年份:1997
- 资助金额:
$ 33.02万 - 项目类别:
Development of Standardized Electronic Treatment Plan Builds for NCI-Supported Clinical Trials Applicable Across Clinical Research Sites; In conjunction with the Big Ten EHR Consortium-Year 2
为 NCI 支持的临床试验开发标准化电子治疗计划,适用于各个临床研究中心;
- 批准号:
10442814 - 财政年份:1997
- 资助金额:
$ 33.02万 - 项目类别:
相似国自然基金
转移相关中性粒细胞(TMAN)代谢重塑促三阴性乳腺癌嗜肺转移的作用与分子机制
- 批准号:82372823
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
抑癌基因FRMD3缺失诱导小鼠自发三阴乳腺癌的作用和机制研究
- 批准号:82372632
- 批准年份:2023
- 资助金额:46 万元
- 项目类别:面上项目
遗传变异调控可变多聚腺苷酸化影响胰腺癌风险的分子流行病学研究
- 批准号:82373663
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
去势环境下CAF来源的CREB3L4通过增强癌细胞脂肪酸合成促进前列腺癌转移的机制研究
- 批准号:82303434
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于空间代谢特征解析活性脂质HAL1介导的YAP相关力学信号传导在胰腺癌侵袭转移中的作用机制研究
- 批准号:82373074
- 批准年份:2023
- 资助金额:46 万元
- 项目类别:面上项目
相似海外基金
Function of mesothelial cells in the tumor microenvironment of pancreatic ductal adenocarcinoma
间皮细胞在胰腺导管腺癌肿瘤微环境中的功能
- 批准号:
10732793 - 财政年份:2022
- 资助金额:
$ 33.02万 - 项目类别:
ST6GalNAc-I/MUC5AC promoting angiogenesis in lung adenocarcinoma
ST6GalNAc-I/MUC5AC促进肺腺癌血管生成
- 批准号:
10513140 - 财政年份:2022
- 资助金额:
$ 33.02万 - 项目类别:
Using photopolymerizable collagen matrices to investigate how progressive stiffening alters lymphatic trafficking of cancer and immune cells in pancreatic ductal adenocarcinoma
使用光聚合胶原基质研究渐进性硬化如何改变胰腺导管腺癌中癌症和免疫细胞的淋巴运输
- 批准号:
10359396 - 财政年份:2022
- 资助金额:
$ 33.02万 - 项目类别:
Using photopolymerizable collagen matrices to investigate how progressive stiffening alters lymphatic trafficking of cancer and immune cells in pancreatic ductal adenocarcinoma
使用光聚合胶原基质研究渐进性硬化如何改变胰腺导管腺癌中癌症和免疫细胞的淋巴运输
- 批准号:
10540414 - 财政年份:2022
- 资助金额:
$ 33.02万 - 项目类别:
Defining receptor-ligand interactions in gastric epithelial immunosurveillance
定义胃上皮免疫监视中的受体-配体相互作用
- 批准号:
10652599 - 财政年份:2022
- 资助金额:
$ 33.02万 - 项目类别: